companydata.dkAmicus Therapeutics ApS: Financial statements 2025
CVR: 39359340
Amicus Therapeutics ApS (CVR 39359340) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,441,140 and a net result of DKK 115,004 compared with DKK 16,475 the year before. That is a decrease of 27.5% compared with the year before. Equity amounted to DKK 424,641. The solvency ratio was 10%. The company had 1 employee in the financial year.
- Gross Profit
- 1,441,140 kr.
- Profit/Loss
- 115,004 kr.
- Equity
- 424,641 kr.
- Total Assets
- 4,230,541 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.4 mio. | 115 t. | 425 t. | 1 |
| 2024 | - | 2 mio. | 16 t. | 310 t. | 1 |
| 2023 | - | 1.7 mio. | 52 t. | 355 t. | 1 |
| 2022 | - | 1.6 mio. | 54 t. | 303 t. | 1 |
| 2021 | - | 644 t. | 19 t. | 249 t. | 1 |
Find more companies like Amicus Therapeutics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Amicus Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK 1,987,087, and the net result was DKK 16,475.
About Amicus Therapeutics ApS
Amicus Therapeutics ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Richard Gideon Morris. The company is owned by Amicus Therapeutics UK Ltd.. The company has 2 employees. In 2025, the company reported a gross profit of DKK 1,441,140 and a net result of DKK 115,004 compared with DKK 16,475 the year before. Equity amounted to DKK 424,641.